Efficacy and Safety of Once-Daily Extended-Release (ER) Hydrocodone in Individuals Previously Receiving ER Morphine for Chronic Pain

Pain Practice - United Kingdom
doi 10.1111/papr.12462
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Extended-Release Morphine Sulfate in Treatment of Severe Acute and Chronic Pain

Journal of Pain Research
AnesthesiologyPain Medicine
2010English

Efficacy and Safety of Morphine Hydrochloride in Cancer Patients With Chronic Pain

Siberian Journal of Oncology
Cancer ResearchOncology
2019English

Safety and Effectiveness of Once Daily Hysingla Extended-Release Tablets in Patients With Baseline Depression or Anxiety

Pain Management
AnesthesiologyPain Medicine
2017English

Effectiveness and Safety of Morphine Sulfate Extended-Release Capsules in Patients With Chronic, Moderate-To-Severe Pain in a Primary Care Setting

Journal of Pain Research
AnesthesiologyPain Medicine
2011English

Real-World Utilization of Once-Daily Extended-Release Abuse Deterrent Formulation of Hydrocodone: A Comparison With the Pre-Approval Randomized Clinical Trials

Journal of Pain Research
AnesthesiologyPain Medicine
2017English

Ocular Hypotensive Efficacy and Safety of Once Daily Carteolol Alginate

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2001English

Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT)

Transplantation
Transplantation
2013English

The Efficacy and Safety of Once-Daily Quetiapine Extended Release in Patients With Schizophrenia Switched From Other Antipsychotics: An Open-Label Study in Chinese Population

BMC Psychiatry
PsychiatryMental Health
2015English

Pain Management in ER

Emergency Care Journal
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy